{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:23:04Z","timestamp":1767853384534,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05271-z","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T19:04:24Z","timestamp":1673291064000},"page":"687-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exploring pain catastrophizing and its associations with low disease activity in rheumatic inflammatory disorders"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7967-0880","authenticated-orcid":false,"given":"Mateusz","family":"Wilk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1678-7309","authenticated-orcid":false,"given":"Are H.","family":"Pripp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9279-5191","authenticated-orcid":false,"given":"Glenn","family":"Haugeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"5271_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/S40744-019-00172-9\/FIGURES\/2","volume":"6","author":"PJ Mease","year":"2019","unstructured":"Mease PJ, Liu M, Rebello S et al (2019) Comparative disease burden in patients with rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis: data from two corona registries. Rheumatol Ther 6:529\u2013542. https:\/\/doi.org\/10.1007\/S40744-019-00172-9\/FIGURES\/2","journal-title":"Rheumatol Ther"},{"key":"5271_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/ANNRHEUMDIS-2019-216243","volume":"79","author":"PH Hsieh","year":"2020","unstructured":"Hsieh PH, Wu O, Geue C et al (2020) Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Ann Rheum Dis 79:771\u2013777. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2019-216243","journal-title":"Ann Rheum Dis"},{"key":"5271_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/S00296-018-4180-4\/FIGURES\/6","volume":"39","author":"K Kr\u00fcger","year":"2019","unstructured":"Kr\u00fcger K, Burmester GR, Wassenberg S et al (2019) Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany. Rheumatol Int 39:131\u2013140. https:\/\/doi.org\/10.1007\/S00296-018-4180-4\/FIGURES\/6","journal-title":"Rheumatol Int"},{"key":"5271_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0218831","volume":"14","author":"T Pilgaard","year":"2019","unstructured":"Pilgaard T, Hagelund L, Stallknecht SE et al (2019) Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis - results of a cross-sectional study. PLoS ONE 14:e021883. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0218831","journal-title":"PLoS ONE"},{"key":"5271_CR5","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1093\/RHEUMATOLOGY\/KEAC210","volume":"61","author":"AM Kerola","year":"2022","unstructured":"Kerola AM, Kazemi A, Rollefstad S et al (2022) All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study. Rheumatology (Oxford) 61:4656\u20134666. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAC210","journal-title":"Rheumatology (Oxford)"},{"key":"5271_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/BTT.S260754","volume":"14","author":"MS Chimenti","year":"2020","unstructured":"Chimenti MS, D\u2019antonio A, Conigliaro P et al (2020) An update for the clinician on biologics for the treatment of psoriatic arthritis. Biologics 14:53\u201375. https:\/\/doi.org\/10.2147\/BTT.S260754","journal-title":"Biologics"},{"key":"5271_CR7","doi-asserted-by":"publisher","first-page":"m2288","DOI":"10.1136\/BMJ.M2288","volume":"370","author":"K Janke","year":"2020","unstructured":"Janke K, Biester K, Krause D et al (2020) Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data. BMJ 370:m2288. https:\/\/doi.org\/10.1136\/BMJ.M2288","journal-title":"BMJ"},{"key":"5271_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.SEMARTHRIT.2022.151996","volume":"54","author":"A Ho","year":"2022","unstructured":"Ho A, Younis I, Le QA (2022) Impact of biologics on health-related quality of life in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials. Semin Arthritis Rheum 54:151996. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2022.151996","journal-title":"Semin Arthritis Rheum"},{"key":"5271_CR9","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1093\/RHEUMATOLOGY\/KEAA860","volume":"60","author":"NMT Roodenrijs","year":"2021","unstructured":"Roodenrijs NMT, van der Goes MC, Welsing PMJ et al (2021) Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatology 60:3778\u20133788. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAA860","journal-title":"Rheumatology"},{"key":"5271_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/S40744-017-0066-2","volume":"4","author":"M Garrido-Cumbrera","year":"2017","unstructured":"Garrido-Cumbrera M, Hillmann O, Mahapatra R et al (2017) Improving the management of psoriatic arthritis and axial spondyloarthritis: roundtable discussions with healthcare professionals and patients. Rheumatol Ther 4:219. https:\/\/doi.org\/10.1007\/S40744-017-0066-2","journal-title":"Rheumatol Ther"},{"key":"5271_CR11","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/EJP.1651","volume":"24","author":"P Vergne-Salle","year":"2020","unstructured":"Vergne-Salle P, Pouplin S, Trouvin AP et al (2020) The burden of pain in rheumatoid arthritis: Impact of disease activity and psychological factors. Eur J Pain 24:1979. https:\/\/doi.org\/10.1002\/EJP.1651","journal-title":"Eur J Pain"},{"key":"5271_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/FNINT.2019.00077\/BIBTEX","volume":"13","author":"T Bar-Shalita","year":"2020","unstructured":"Bar-Shalita T, Cermak SA (2020) Multi-sensory responsiveness and personality traits predict daily pain sensitivity. Front Integr Neurosci 13:77. https:\/\/doi.org\/10.3389\/FNINT.2019.00077\/BIBTEX","journal-title":"Front Integr Neurosci"},{"key":"5271_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/S11920-008-0042-1","volume":"10","author":"TO Bruce","year":"2008","unstructured":"Bruce TO (2008) Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr Psychiatry Rep 10:258\u2013264. https:\/\/doi.org\/10.1007\/S11920-008-0042-1","journal-title":"Curr Psychiatry Rep"},{"key":"5271_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/NRRHEUM.2016.112","volume":"12","author":"JA Sturgeon","year":"2016","unstructured":"Sturgeon JA, Finan PH, Zautra AJ (2016) Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol 12:532. https:\/\/doi.org\/10.1038\/NRRHEUM.2016.112","journal-title":"Nat Rev Rheumatol"},{"key":"5271_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/0253-7176.106012","volume":"34","author":"L Leung","year":"2012","unstructured":"Leung L (2012) Pain catastrophizing: an updated review. Indian J Psychol Med 34:204\u2013217. https:\/\/doi.org\/10.4103\/0253-7176.106012","journal-title":"Indian J Psychol Med"},{"key":"5271_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/ACR.23339","volume":"70","author":"HB Hammer","year":"2018","unstructured":"Hammer HB, Uhlig T, Kvien TK, Lampa J (2018) Pain catastrophizing, subjective outcomes, and inflammatory assessments including ultrasound: results from a longitudinal study of rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 70:703\u2013712. https:\/\/doi.org\/10.1002\/ACR.23339","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5271_CR17","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/J.PAIN.0000000000001959","volume":"161","author":"R Zhaoyang","year":"2020","unstructured":"Zhaoyang R, Martire LM, Darnall BD (2020) Daily pain catastrophizing predicts less physical activity and more sedentary behavior in older adults with osteoarthritis. Pain 161:2603\u20132610. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000001959","journal-title":"Pain"},{"key":"5271_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1080\/09638288.2017.1300691","volume":"40","author":"EJ Shim","year":"2018","unstructured":"Shim EJ, Hahm BJ, Go DJ et al (2018) Modeling quality of life in patients with rheumatic diseases: the role of pain catastrophizing, fear-avoidance beliefs, physical disability, and depression. Disabil Rehabil 40:1509\u20131516. https:\/\/doi.org\/10.1080\/09638288.2017.1300691","journal-title":"Disabil Rehabil"},{"key":"5271_CR19","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/S11136-020-02457-X","volume":"29","author":"CM Galvez-S\u00e1nchez","year":"2020","unstructured":"Galvez-S\u00e1nchez CM, Montoro CI, Duschek S, del Paso GAR (2020) Pain catastrophizing mediates the negative influence of pain and trait-anxiety on health-related quality of life in fibromyalgia. Qual Life Res 29:1871\u20131881. https:\/\/doi.org\/10.1007\/S11136-020-02457-X","journal-title":"Qual Life Res"},{"key":"5271_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/S00221-007-1206-7","volume":"186","author":"I Weissman-Fogel","year":"2008","unstructured":"Weissman-Fogel I, Sprecher E, Pud D (2008) Effects of catastrophizing on pain perception and pain modulation. Exp Brain Res 186:79\u201385. https:\/\/doi.org\/10.1007\/S00221-007-1206-7","journal-title":"Exp Brain Res"},{"key":"5271_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/ABM\/KAAA004","volume":"54","author":"TA Toledo","year":"2020","unstructured":"Toledo TA, Kuhn BL, Payne MF et al (2020) The effect of pain catastrophizing on endogenous inhibition of pain and spinal nociception in Native Americans: results from the Oklahoma study of Native American pain risk. Ann Behav Med 54:575\u2013594. https:\/\/doi.org\/10.1093\/ABM\/KAAA004","journal-title":"Ann Behav Med"},{"key":"5271_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.21307\/ane-2019-005","volume":"79","author":"MA Ferdek","year":"2019","unstructured":"Ferdek MA, Adamczyk AK, van Rijn CM et al (2019) Pain catastrophizing is associated with altered EEG effective connectivity during pain-related mental imagery. Acta Neurobiol Exp (Wars) 79:53\u201372. https:\/\/doi.org\/10.21307\/ane-2019-005","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"5271_CR23","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1093\/PM\/PNY008","volume":"19","author":"LD Ellingson","year":"2018","unstructured":"Ellingson LD, Stegner AJ, Schwabacher IJ et al (2018) Catastrophizing interferes with cognitive modulation of pain in women with fibromyalgia. Pain Med 19:2408\u20132422. https:\/\/doi.org\/10.1093\/PM\/PNY008","journal-title":"Pain Med"},{"key":"5271_CR24","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/ANNRHEUMDIS-2017-211284","volume":"76","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Kristianslund EK, Sexton J et al (2017) Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis 76:1906\u20131910. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2017-211284","journal-title":"Ann Rheum Dis"},{"key":"5271_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/S00296-021-05070-4","volume":"42","author":"M Wilk","year":"2022","unstructured":"Wilk M, \u0141osi\u0144ska K, Pripp AH et al (2022) Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life. Rheumatol Int 42:669\u2013682. https:\/\/doi.org\/10.1007\/S00296-021-05070-4","journal-title":"Rheumatol Int"},{"key":"5271_CR26","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ARD.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588. https:\/\/doi.org\/10.1136\/ARD.2010.138461","journal-title":"Ann Rheum Dis"},{"key":"5271_CR27","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/ART.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665\u20132673. https:\/\/doi.org\/10.1002\/ART.21972","journal-title":"Arthritis Rheum"},{"key":"5271_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ARD.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R et al (2009) The development of assessment of spondyloarthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783. https:\/\/doi.org\/10.1136\/ARD.2009.108233","journal-title":"Ann Rheum Dis"},{"key":"5271_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.14236\/JHI.V22I3.177","volume":"22","author":"S de Lusignan","year":"2015","unstructured":"de Lusignan S, Crawford L, Munro N (2015) Creating and using real-world evidence to answer questions about clinical effectiveness. BMJ Health Care Inform 22:368\u2013373. https:\/\/doi.org\/10.14236\/JHI.V22I3.177","journal-title":"BMJ Health Care Inform"},{"key":"5271_CR30","volume-title":"Multivariate data analysis: international version","author":"JF Hair","year":"2010","unstructured":"Hair JF et al (2010) Multivariate data analysis: international version. Pearson, New Jersey"},{"key":"5271_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S40744-022-00490-5","volume":"2022","author":"A Brkic","year":"2022","unstructured":"Brkic A, \u0141osi\u0144ska K, Pripp AH et al (2022) Remission or not remission, that\u2019s the question: shedding light on remission and the impact of objective and subjective measures reflecting disease activity in rheumatoid arthritis. Rheumatol Ther 2022:1\u201317. https:\/\/doi.org\/10.1007\/S40744-022-00490-5","journal-title":"Rheumatol Ther"},{"key":"5271_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/RMDOPEN-2021-002013","volume":"8","author":"N Paulshus Sundlis\u00e6ter","year":"2022","unstructured":"Paulshus Sundlis\u00e6ter N, Sundin U, Aga AB et al (2022) Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR\/EULAR Boolean remission in a treat-to-target study. RMD Open 8:e002013. https:\/\/doi.org\/10.1136\/RMDOPEN-2021-002013","journal-title":"RMD Open"},{"key":"5271_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/S13075-021-02430-0","volume":"23","author":"WB Nowell","year":"2021","unstructured":"Nowell WB, Gavigan K, Kannowski CL et al (2021) Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower. Arthritis Res Ther 23:53. https:\/\/doi.org\/10.1186\/S13075-021-02430-0","journal-title":"Arthritis Res Ther"},{"key":"5271_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/EJP.1541","volume":"24","author":"I Meisingset","year":"2020","unstructured":"Meisingset I, Vasseljen O, V\u00f8llestad NK et al (2020) Novel approach towards musculoskeletal phenotypes. Eur J Pain 24:921\u2013932. https:\/\/doi.org\/10.1002\/EJP.1541","journal-title":"Eur J Pain"},{"key":"5271_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/ANNRHEUMDIS-2020-217344","volume":"80","author":"G Nagy","year":"2021","unstructured":"Nagy G, Roodenrijs NMT, Welsing PMJ et al (2021) EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 80:31\u201335. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2020-217344","journal-title":"Ann Rheum Dis"},{"key":"5271_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/S41584-020-00541-7","volume":"17","author":"MH Buch","year":"2021","unstructured":"Buch MH, Eyre S, McGonagle D (2021) Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis. Nat Rev Rheumatol 17:17\u201333. https:\/\/doi.org\/10.1038\/S41584-020-00541-7","journal-title":"Nat Rev Rheumatol"},{"key":"5271_CR37","first-page":"E959","volume":"25","author":"R Diab","year":"2022","unstructured":"Diab R, Bomar R, Slaven J et al (2022) Nurse-supported web-based cognitive behavioral therapy for chronic musculoskeletal pain: a randomized controlled trial. Pain Physician 25:E959\u2013E968","journal-title":"Pain Physician"},{"key":"5271_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0163132","volume":"11","author":"SJ Park","year":"2016","unstructured":"Park SJ, Yoon DM, Yoon KB et al (2016) Factors associated with higher reported pain levels in patients with chronic musculoskeletal pain: a cross-sectional, correlational analysis. PLoS ONE 11:e0163132. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0163132","journal-title":"PLoS ONE"},{"key":"5271_CR39","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/PM\/PNZ373","volume":"21","author":"S Sharma","year":"2020","unstructured":"Sharma S, Ferreira-Valente A, Williams ACDC et al (2020) Group differences between countries and between languages in pain-related beliefs, coping, and catastrophizing in chronic pain: a systematic review. Pain Med 21:1847\u20131862. https:\/\/doi.org\/10.1093\/PM\/PNZ373","journal-title":"Pain Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05271-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05271-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05271-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T03:04:46Z","timestamp":1678331086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05271-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["5271"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05271-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mateusz Wilk: none declared; Are Hugo Pripp: none declared; Mariusz Korkosz: none declared; Glenn Haugeberg: Previous founder and shareholder in the company DiaGraphIT AS; manufacturing the GoTreatIT Rheuma computer tool used to collect data in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The approval for this study was given by the regional ethical committee (Regional etisk komite Midt-Norge 2010\/3078) to analyse anonymised data from outpatient clinics in Norway. No consent from patients was needed according to the ethical committee, as all the data described above were collected as part of clinical care to facilitate treatment decisions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}